Menu

Search

David Kok

David Kok

Radiation Oncologist at Peter Mac; Course Coordinator, Masters of Cancer Sciences, The University of Melbourne
Dr David Kok is a Radiation Oncologist and Medical Educator dually employed by the Peter MacCallum Cancer Centre and The University of Melbourne.
He holds numerous senior roles, including being Peter Mac's Associate Director of Radiation Oncology (Education) and Director of Peter Mac's Monash Moorabbin campus.
Clinically, he treats all tumour subtypes but has a particular interest in skin, urological and neurological malignancies. He has expertise in the use of Stereotactic Radiosurgery, VMAT and Intensity Modulated radiotherapy to achieve the best possible outcomes for his patients.
David is also an award winning medical educator. He completed an education degree alongside his medical degree and also completed a medical education fellowship before taking up his current position as the inaugural Course Convenor of the University of Melbourne's Master of Cancer Science Degree - a program delivered jointly by the University of Melbourne and the Victorian Comprehensive Cancer Centre. Delivered online using a variety of innovative methods including interactive case scenarios, fully animated videos and virtual reality simulations, it has been recognised as a sector-leading degree with numerous international accolades and is one of the University's fastest growing degrees. In addition he has led the design of two short courses and three microcertifications for the University.
David sits on a range of national and international educational committees. This includes being the Chair of the VCCC Alliance's Cancer Education and Training Advisory Committee - the overarching educational committee that sits across the Alliance's 10 hospital's and academic institutions - and Chief of Training and Assessment for the Royal Australian and New Zealand College of Radiology's Faculty of Radiation Oncology. He is also an Adjunct Associate Professor in the Monash University Department of Medical Imaging and Radiation Sciences. He has published and lectured widely relating to best practice in tertiary and postgraduate medical education.

What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?

Oct 25, 2024 12:06 pm UTC| Health

Prostate cancer is Australias most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start invading neighbouring...

1 

Economy

Asian Stocks Mixed as China, Japan Factory Data Disappoint; India, Korea Decline on Geopolitical Risks

Asian stock markets were mostly flat on Wednesday as investors weighed weak factory activity data from China and Japan, alongside Australian inflation figures and heightened regional tensions. Chinas official manufacturing...

Oil Prices Dip Amid Tariff Concerns, Rising Inventories, and OPEC+ Output Worries

Oil prices slipped in early Asian trading Wednesday, pressured by renewed concerns over global economic growth and fuel demand due to U.S. tariff policies and rising crude inventories. Brent crude futures fell 17 cents, or...

U.S. Stock Futures Dip as Investors Monitor Trade Developments, Earnings, and Key Data

U.S. stock futures slipped Tuesday evening as investors digested signs of easing trade tensions, soft economic data, and awaited major corporate earnings. SP 500 futures fell 0.2% to 5,571.75, while Nasdaq 100 futures...

India Eyes Swift U.S. Trade Deal with Rare Forward MFN Clause

India is accelerating trade talks with the U.S., offering significant concessions to secure a fast-track deal ahead of President Donald Trumps proposed 26% reciprocal tariff deadline in July. According to Indian government...

Sweden’s Q1 2025 GDP Stalls, Missing Growth Forecasts

Swedens economy stagnated in the first quarter of 2025, with gross domestic product (GDP) showing no growth compared to the previous three months, according to preliminary data from the Statistics Office released Tuesday....

Politics

Trump Touts Economic Record, Promises Tax Cuts at Michigan Rally Amid Recession Fears

President Donald Trump rallied supporters in Warren, Michigan, marking his first 100 days in office with bold claims about the U.S. economy, promises of sweeping tax cuts, and sharp criticism of Democrats. Speaking near...

Tensions Escalate as China, U.S., and Philippines Conduct Rival Patrols in South China Sea

Chinas navy conducted a patrol in the South China Sea on Tuesday, accusing the Philippines of provocations as Filipino and U.S. forces carried out joint aerial patrols over the disputed waters. The move comes amid rising...

U.S. Defense Secretary Scraps Women, Peace and Security Program Citing Military Focus

U.S. Defense Secretary Pete Hegseth announced Tuesday the cancellation of the Women, Peace, and Security (WPS) program, originally enacted by President Donald Trump in 2017 to promote womens participation in global peace...

U.S. Urges India and Pakistan to Avoid Escalation After Kashmir Attack

U.S. Secretary of State Marco Rubio is set to hold talks with his Indian and Pakistani counterparts in an effort to prevent further escalation following a deadly militant attack in India-administered Kashmir. The State...

Trump Jokes About Becoming Pope After Death of Francis

U.S. President Donald Trump joked on Tuesday that hed like to succeed Pope Francis, who passed away last week at the age of 88. When asked who he would prefer as the next leader of the Catholic Church, Trump quipped, Id...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Xiaomi Unveils MiMo AI Model, Shares Surge 5% on Breakthrough Launch

Xiaomi Corp (HK:1810) launched its first open-source large language model, MiMo, on Wednesday, marking its official entry into the competitive artificial intelligence space. The debut sent Xiaomis Hong Kong-listed shares...

Alibaba Launches Qwen 3 AI Model Amid Intensifying China Tech Competition

Chinese tech giant Alibaba Group (NYSE:BABA) unveiled Qwen 3 on Tuesday, a next-generation AI model featuring hybrid reasoning capabilities aimed at boosting performance and adaptability. The move underscores Alibabas...

Amazon Enters Satellite Internet Race with First Kuiper Deployment

Amazon (NASDAQ:AMZN) has officially entered the satellite broadband market with the successful launch of 27 operational satellites for Project Kuiper, its high-speed internet initiative aimed at rivaling SpaceXs Starlink....

Chinese AI App DeepSeek Resumes Downloads in South Korea After Privacy Update

Chinese artificial intelligence app DeepSeek has resumed availability in South Koreas app stores after a two-month suspension due to data protection concerns. Downloads were halted in February when South Koreas Personal...

Nvidia Shares Dip as Huawei Tests Rival AI Chip

Nvidia Corporation (NASDAQ: NVDA) slipped in after-hours trading on Sunday, following reports that Chinas Huawei is testing a powerful artificial intelligence chip aimed at challenging Nvidias dominance. NVDA shares fell...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.